Granite Point Capital Management, L.P. Fortress Biotech, Inc. Transaction History

Granite Point Capital Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 05, 2019	SELL	$0.57 - $1.53 $273,505 - $734,147	-479,835 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$1.44 - $3.13 $237 - $516	-165 Reduced 0.03%	479,835 $768,000
Q2 2018 Aug 13, 2018	BUY	$2.92 - $5.1 $1.4 Million - $2.45 Million	480,000 New	480,000 $1.43 Million

1.01M

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $189M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

Get notified when there are updates to the investment portfolio of Granite Point Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Granite Point Capital Management, L.P. with notifications on news.